MTOR and chordoma: However, investigation into mTOR activity in chordomas is required before offering such treatments as evidence also exists that the locus harbouring mTOR in chordomas is a region where there is frequent genomic loss (frequency of 0.57) (Scheil et al, 2001; Hallor et al, 2008).